OpenAI CEO Sam Altman's decision to join President Trump's "Stargate" AI initiative marks a stark reversal for the tech CEO, ...
Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
Sam Altman, the CEO of OpenAI, has announced a shift in his previously critical perspective on President Donald Trump.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback